INTELLIA THERAPEUTICS, INC.
NTLA US45826J1051
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 111% | -71% | -12% | -62% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Schultes Birgit C EX VP |
17.38 USD |
31 Sold |
539 USD |
01/10/2025 | 01/10/2025 |
| Dube Michael P VP |
17.38 USD |
1,871 Sold |
32,518 USD |
01/10/2025 | 01/10/2025 |
| Chase William J |
10.03 USD |
100,000 Bought |
1,003,000 USD |
20/08/2025 | 20/08/2025 |
| Dulac Edward J Iii EX VP |
14.02 USD |
7,462 Sold |
104,617 USD |
23/07/2025 | 23/07/2025 |
| Dube Michael P CCO |
9.95 USD |
2,503 Sold |
24,905 USD |
02/07/2025 | 02/07/2025 |
| Clark Eliana EX VP |
9.82 USD |
1,022 Sold |
10,036 USD |
01/07/2025 | 01/07/2025 |
| Goodman Jesse |
9.23 USD |
1,547 Sold |
14,279 USD |
30/06/2025 | 01/07/2025 |
| Goodman Jesse |
9.56 USD |
1,547 Sold |
14,789 USD |
30/06/2025 | 30/06/2025 |
| Bhanji Muna |
8.50 USD |
265 Sold |
2,253 USD |
29/04/2025 | 29/04/2025 |
| Basta James EX VP |
8.99 USD |
2,572 Sold |
23,122 USD |
01/03/2025 | 04/03/2025 |